Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0011 USD
Change Today 0.00 / 0.00%
Volume 0.0
RGBOQ On Other Exchanges
As of 8:10 PM 08/19/15 All times are local (Market data is delayed by at least 15 minutes).

regen biologics inc (RGBOQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/24/15 - $0.01
52 Week Low
08/12/15 - $0.0011
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for REGEN BIOLOGICS INC (RGBOQ)

Related News

No related news articles were found.

regen biologics inc (RGBOQ) Related Businessweek News

No Related Businessweek News Found

regen biologics inc (RGBOQ) Details

ReGen Biologics Inc. designs, develops, manufactures, and markets medical devices for the repair and generation of soft tissue in humans, primarily for orthopedic applications. The company’s proprietary collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular, and drug delivery. Its products include Menaflex collagen meniscus implant device, for use in surgical procedures for the reinforcement and repair of soft tissue injuries of the medial meniscus; and SharpShooter Tissue Repair System, an instrument that allows surgeons to place needles in hard-to-reach locations of the meniscus. The company sells its products in the United States, the European Union, the Republic of South Africa, Canada, Australia, Chile, and Japan. The company was formerly known as Aros Corp and changed its name to ReGen Biologics Inc. in November, 2002. ReGen Biologics Inc. was founded in 1987 and is headquartered in Hackensack, New Jersey. On April 8, 2011, ReGen Biologics Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 14, 2011.

15 Employees
Last Reported Date: 05/28/09
Founded in 1987

regen biologics inc (RGBOQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGBOQ:US $0.00 USD 0.00

RGBOQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RGBOQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation RGBOQ Industry Range
No financial data is available for RGBOQ.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGEN BIOLOGICS INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at